This study was designed to test the hypothesis that circulating IGF‐1 deficiency promotes the development of CMHs, by exacerbating hypertension‐induced vascular oxidative stress and MMP activation and/or by impairing microvascular structural adaptation to hypertension. The gene discussed is IGF1; the disease is hypertensive disorder.